The elevation in cyclin D levels in ovarian cancer cells with low levels of G1 CDK inhibitors unbalances G1 cell cycle regulation and enables a premature exit from the quiescent state, with a loss of sequestered E2F4 from p130/Rb2, with subsequent apoptosis and cell death (24). This evidence concerns the gene E2F4 and ovarian cancer.